Salerno S, Messana JM, Gremel GW, Dahlerus C, Hirth RA, Han P, et al. COVID-19 Risk Factors and Mortality Outcomes among Medicare Patients Receiving Long-term Dialysis. JAMA Netw Open. 2021;4(11):1–15.

Article  Google Scholar 

Couchoud C, Bayer F, Ayav C, Béchade C, Brunet P, Chantrel F, et al. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int. 2020;98(6):1519–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng JH, Hirsch JS, Wanchoo R, Sachdeva M, Sakhiya V, Hong S, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98(6):1530–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Kidney Int. 2020;98(1):20–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hilbrands LB, Duivenvoorden R, Vart P, Franssen CFM, Hemmelder MH, Jager KJ, et al. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration. Nephrol Dial Transplant. 2020;35(11):1973–83.

Article  CAS  PubMed  Google Scholar 

Jager KJ, Kramer A, Chesnaye NC, Couchoud C, Sánchez-Álvarez JE, Garneata L, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int. 2020;98(6):1540–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kho MML, Reinders MEJ, Baan CC, Baarle D Van, Bemelman FJ, Diavatopoulos DA, et al. The RECOVAC IR study : the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease , on dialysis or living with a kidney transplant. Nephrol Dial Transplant. 2021;36(9):1761–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francis A, Baigent C, Ikizler TA, Cockwell P, Jha V. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action. Vol. 99, Kidney International. Elsevier B.V.; 2021. 791–3.

Simon B, Rubey H, Treipl A, Gromann M, Hemedi B, Zehetmayer S, et al. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls. 2021;2204–6.

de Meester J, de Bacquer D, Naesens M, Meijers B, Couttenye MM, de Vriese AS. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: A regionwide registry study. J Am Soc Nephrol. 2021;32(2):385–96.

Article  PubMed  Google Scholar 

Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature [Internet]. 2020;584(7821):430–6. Available from: https://doi.org/10.1038/s41586-020-2521-4.

Semenzato L, Botton J, Drouin J, Cuenot F, Dray-Spira R, Weill A, et al. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people. Lancet Reg Heal - Eur. 2021;8.

Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. Hepatitis B Vaccine in Patients Receiving Hemodialysis. N Engl J Med. 1984;311(8):496–501.Available from: https://doi.org/10.1056/NEJM198408233110803.

Fuchshuber A, Kuhnemund O, Keuth B, Lutticken R, Michalk D, Querfeld U. Nephrology Dialysis Transplantation Pneumococcal vaccine in children and young adults with chronic renal disease. 1996;468–73.

Trial L term HAO label. Immunogenicity of a Standard Trivalent Influenza Vaccine in Patients on. YAJKD [Internet]. 2009;54(1):77–85. Available from: https://doi.org/10.1053/j.ajkd.2008.11.032.

Gallego-valcarce E, Shabaka A, Leon-poo M, Gruss E, Acedo-sanz JM, Cordón A, et al. Humoral Response Following Triple Dose of mRNA Vaccines Against SARS-CoV-2 in Hemodialysis Patients : Results After 1 Year of. 2022;9:1–12.

Peiyao R, Mengjie Y, Xiaogang S, Wenfang H. Immunogenicity and safety of SARS-CoV- vaccine in hemodialysis patients : A systematic review and.

Galmiche S, Binh L, Nguyen L, Tartour E, Lamballerie X De, Wittkop L, et al. Immunological and clinical ef fi cacy of COVID-19 vaccines in immunocompromised populations : a systematic review. Clin Microbiol Infect [Internet]. 2022;28(2):163–77. Available from: https://doi.org/10.1016/j.cmi.2021.09.036.

Angel-korman A, Peres E, Bryk G, Lustig Y, Indenbaum V, Amit S, et al. Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel : the case for a third vaccine dose. Clin Kidney J. 2022;15(2):226–34.

Article  CAS  PubMed  Google Scholar 

Espi M, Charmetant X, Barba T, Mathieu C, Pelletier C, Koppe L, et al. No Title. 2020.

Falahi S. Immunogenicity of COVID ‐ 19 mRNA vaccines in hemodialysis patients : Systematic review and meta ‐ analysis. 2022.

Wang H hao, Wu J ling, Chang M yu, Wu H mian, Ho L chun, Chi P jui, et al. Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis : A Prospective Cohort Study. 2022;

Garcia P, Anand S, Han J, Montez-Rath ME, Sun S, Shang T, et al. COVID-19 Vaccine Type and Humoral Immune Response in Patients Receiving Dialysis. J Am Soc Nephrol. 2022;33(1):33–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murt A. Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients : Is inactivated vaccine effective ? Ther Apher Dial. 2022;26(4):769–74.

Article  CAS  PubMed  Google Scholar 

Anand S, Montez-Rath ME, Han J, Garcia P, Cadden L, Hunsader P, et al. SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis. Ann Intern Med [Internet]. 2021;175(3):371–8. Available from: https://doi.org/10.7326/M21-4176.

Hsu CM, Weiner DE, Manley HJ, Aweh GN, Ladik V, Frament J, et al. Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months. Clin J Am Soc Nephrol. 2022;17(3):403–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strategic Advisory Group of Experts (SAGE), Parker E, Desai S, Wilder-Smith A, Hombach J, Marti M. Interim recommendations for an extended primary series with an additional vaccine dose for COVID-19 vaccination in immunocompromised persons. 2023.

Rodr D, Cuadrado E, Bedini L. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients. 2022;

Melin J, Svensson MK, Albinsson B, Winqvist O, Pauksens K. A third dose SARS ‑ CoV ‑ 2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients. 2022;

Shashar M. Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients. Am J Nephrol. 2022;53(2–3):207–14.

Article  CAS  PubMed  Google Scholar 

Verdier JF, Boyer S, Chalmin F, Jeribi A, Egasse C, Maggi MF, et al. Response to three doses of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine: a retrospective study of a cohort of haemodialysis patients in France. BMC Nephrol [Internet]. 2022;23(1):1–13. Available from: https://doi.org/10.1186/s12882-022-02751-5.

Wijewickrama ES, Herath N. Global Dialysis Perspective: Sri Lanka. Kidney360. 2022;3(9):1603–6.

Article  PubMed  PubMed Central  Google Scholar 

Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat Biotechnol [Internet]. 2020;38(9):1073–8. Available from: https://doi.org/10.1038/s41587-020-0631-z.

Kristiansen PA, Page M, Bernasconi V, Mattiuzzo G, Dull P, Makar K, et al. WHO International Standard for anti-SARS-CoV-2 immunoglobulin. Lancet [Internet]. 2021;397(10282):1347–8. Available from: https://doi.org/10.1016/S0140-6736(21)00527-4.

Zhu F, Althaus T, Tan CW, Costantini A, Chia WN, Van Vinh CN, et al. WHO international standard for SARS-CoV-2 antibodies to determine markers of protection. The Lancet Microbe. 2022;3(2):e81–2.

Article  CAS  PubMed  Google Scholar 

Lee SW. Regression analysis for continuous independent variables in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2:1–8.

Article  Google Scholar 

Parker EPK, Horne EMF, Hulme WJ, Tazare J, Zheng B, Carr EJ, et al. Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. Lancet Reg Heal - Eur [Internet]. 2023;30:100636. Available from: https://doi.org/10.1016/j.lanepe.2023.100636.

Kitamura M, Takazono T, Yamamoto K, Harada T, Funakoshi S, Mukae H, et al. Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case–control observational study. Ren Replace Ther [Internet]. 2022;8(1):1–9. Available from: https://doi.org/10.1186/s41100-022-00397-5.

Bai S, Dhrolia M, Qureshi H, Qureshi R, Nasir K, Ahmad A. Comparison of COVID-19 Inactivated Virus Vaccine Immunogenicity Between Healthy Individuals and Patients on Hemodialysis: A Single-Center Study From Pakistan. Cureus. 2022;14(4):e24153.

PubMed  PubMed Central  Google Scholar 

Füessl L, Lau T, Lean I, Hasmann S, Riedl B, Arend FM, et al. Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients. 2022;1–10.

Behrens GMN, Cossmann A, Stankov MV. Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting : The COVID-19 Contact ( CoCo ) Study in Healthcare Professionals. Infect Dis Ther. 2020;9(4):837–49.

Article  PubMed  PubMed Central  Google Scholar 

Cheng CY, Hsiao SH, Fang TC, Lin YC, Wang JCC, Hung CS, et al. SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients. J Infect. 2022;84(6):e98–100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ranasinghe AV, Kumara GWGP, Karunarathna RH, De Silva AP, Sachintani KGD, Gunawardena JMCN, et al. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: An analysis of 30,566 patients. BMC Nephrol. 2019;20(1):1–11.

Article  Google Scholar 

Ben-Dov IZ, Oster Y, Tzukert K, Alster T, Bader R, Israeli R, et al. Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months follow-up. J Nephrol [Internet]. 2022;35(1):153–64. Available from: https://doi.org/10.1007/s40620-021-01210-y

Speer C, Goth D, Benning L, Buylaert M, Schaier M, Grenz J, et al. Early humoral responses of hemodialysis patients after covid-19 vaccination with bnt162b2. Clin J Am Soc Nephrol. 2021;16(7):1073–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Muhaiteeb A, AlSahow A, Al-Yousef A, AlHelal B, Alrajab H, Bahbahani Y, et al. Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients—A prospective observational study. Hemodial Int. 2022;26(2):216–22.

Article  PubMed  PubMed Central  Google Scholar 

Falahi S, Sayyadi H, Kenarkoohi A. Immunogenicity of COVID-19 mRNA vaccines in hemodialysis patients: Systematic review and meta-analysis. Heal Sci Reports. 2022;5(6).

Article  Google Scholar 

Affeldt P, Koehler FC, Brensing KA, Adam V, Burian J, Butt L, et al. Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients. 2022;1–14.

Cheng CY, Fang TC, Liao HW, Chen TH, Chang JH, Lin YC, et al. The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection. Vaccines. 2022;10(2).

Ling TC, Chen PL, Li NY, Ko WC, Sun CY, Chao JY, et al. Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis. Microbiol Spectr. 2023;11(2):1–13.

Article  CAS  Google Scholar 

Prasithsirikul W, Nopsopon T, Phutrakool P, Suwanwattana P, Kantagowit P, Pongpirul W, et al. ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis. Vaccines. 2022;10(6):959.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glück V, Grobecker S, Köstler J, Tydykov L, Bertok M, Weidlich T, et al. Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel. Infection [Internet]. 2022;50(2):439–46. Available from: https://doi.org/10.1007/s15010-021-01703-9.

Gilboa M, Regev-Yochay G, Mandelboim M, Indenbaum V, Asraf K, Fluss R, et al. Durability of Immune Response after COVID-19 Booster Vaccination and Association with COVID-19 Omicron Infection. JAMA Netw Open. 2022;5(9):E2231778.

Article  PubMed  PubMed Central  Google Scholar 

Sanders JSF, Messchendorp AL, De Vries RD, Baan CC, Van Baarle D, Van Binnendijk R, et al. Antibody and T-Cell Responses 6 Months after Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney Transplant. Clin Infect Dis [Internet]. 2023;76(3):E188--E199. Available from: https://doi.org/10.1093/cid/ciac557.

Bassi J, Giannini O, Silacci-Fregni C, Pertusini L, Hitz P, Terrot T, et al. Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients. PLoS One. 2022;17(2):1–24.

Article  Google Scholar 

Espi M, Charmetant X, Mathieu C, Lalande A, Decimo D, Koppe L, et al. Rapid Waning of Immune Memory Against SARS-CoV-2 in Maintenance Hemodialysis Patients After mRNA Vaccination and Impact of a Booster Dose. Kidney Int Reports [Internet]. 2023;8(4):907–11. Available from: https://doi.org/10.1016/j.ekir.2023.01.004.

Wang X, Han M, Fuentes LR, Thwin O, Grobe N, Wang K, et al. SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients. Front Nephrol. 2022;2:1–7.